NCT02909361
Breast Cancer Type: HR+ & HER2-negative
Hormone Mutations: ER+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Not Applicable
Drug Category: Endocrine (Hormone) Therapy
Key Eligibility Criteria:
Gender: Female
Age: 18 Years and older (Adult, Senior)
Location of Metastases:
Additional Notes: Must have ER+ tumor(s)
Exclusions:
https://ClinicalTrials.gov/show/NCT02909361